Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hypertension is considered the most important risk factor for cardiovascular diseases, but its control is poor worldwide. We aimed to assess the availability and affordability of blood pressure-lowering medicines, and the association with use of these medicines and blood pressure control in countries at varying levels of economic development. METHODS: We analysed the availability, costs, and affordability of blood pressure-lowering medicines with data recorded from 626 communities in 20 countries participating in the Prospective Urban Rural Epidemiological (PURE) study. Medicines were considered available if they were present in the local pharmacy when surveyed, and affordable if their combined cost was less than 20% of the households' capacity to pay. We related information about availability and affordability to use of these medicines and blood pressure control with multilevel mixed-effects logistic regression models, and compared results for high-income, upper-middle-income, lower-middle-income, and low-income countries. Data for India are presented separately because it has a large generic pharmaceutical industry and a higher availability of medicines than other countries at the same economic level. FINDINGS: The availability of two or more classes of blood pressure-lowering drugs was lower in low-income and middle-income countries (except for India) than in high-income countries. The proportion of communities with four drug classes available was 94% in high-income countries (108 of 115 communities), 76% in India (68 of 90), 71% in upper-middle-income countries (90 of 126), 47% in lower-middle-income countries (107 of 227), and 13% in low-income countries (nine of 68). The proportion of households unable to afford two blood pressure-lowering medicines was 31% in low-income countries (1069 of 3479 households), 9% in middle-income countries (5602 of 65 471), and less than 1% in high-income countries (44 of 10 880). Participants with known hypertension in communities that had all four drug classes available were more likely to use at least one blood pressure-lowering medicine (adjusted odds ratio [OR] 2·23, 95% CI 1·59-3·12); p<0·0001), combination therapy (1·53, 1·13-2·07; p=0·054), and have their blood pressure controlled (2·06, 1·69-2·50; p<0·0001) than were those in communities where blood pressure-lowering medicines were not available. Participants with known hypertension from households able to afford four blood pressure-lowering drug classes were more likely to use at least one blood pressure-lowering medicine (adjusted OR 1·42, 95% CI 1·25-1·62; p<0·0001), combination therapy (1·26, 1·08-1·47; p=0·0038), and have their blood pressure controlled (1·13, 1·00-1·28; p=0·0562) than were those unable to afford the medicines. INTERPRETATION: A large proportion of communities in low-income and middle-income countries do not have access to more than one blood pressure-lowering medicine and, when available, they are often not affordable. These factors are associated with poor blood pressure control. Ensuring access to affordable blood pressure-lowering medicines is essential for control of hypertension in low-income and middle-income countries. FUNDING: Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Canadian Institutes of Health Research Strategy for Patient Oriented Research through the Ontario SPOR Support Unit, the Ontario Ministry of Health and Long-Term Care, pharmaceutical companies (with major contributions from AstraZeneca [Canada], Sanofi Aventis [France and Canada], Boehringer Ingelheim [Germany amd Canada], Servier, and GlaxoSmithKline), Novartis and King Pharma, and national or local organisations in participating countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The reason may be that lower income was associated with a reduced likelihood of achieving BP control,56 as a large proportion (31%) of households in low-income countries were unable to afford two BP-lowering medicines compared to 9% in middle-income countries and 1% in high-income countries.57”
From Effectiveness of digital health interventions on blood pressure control, lifestyle behaviours and adherence to medication in patients with hypertension in low-income and middle-income countries: a systematic review and meta-analysis of randomised controlled trials (2024) · cites this paper as [57]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transforming Our World: The 2030 Agenda for Sustainable Development
(2018) · A New Era in Global Health · doi:10.1891/9780826190123.ap02 · Cited by 19,351
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Household catastrophic health expenditure: a multicountry analysis
Xu, K., Evans, D. B., Kawabata, K., Zeramdini, R., Klavus, J., & Murray, C. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13861-5 · Cited by 2,309
Chow, C. K. (2013) · JAMA · doi:10.1001/jama.2013.184182 · Cited by 1,991
Self-citationDiabetes, Hypertension, and Cardiovascular Disease: An Update
Sowers, J. R., Epstein, M., & Frohlich, E. D. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1053 · Cited by 1,332
Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus
Gress, T. W., Nieto, F. J., Shahar, E., Wofford, M. R., & Brancati, F. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421301 · Cited by 1,202
Cardiovascular risk and events in 17 low-, middle-, and high-income countries
Yusuf, S., Rangarajan, S., Teo, K., Islam, S., Li, W., Liu, L., Bo, J., Lou, Q., Lu, F., Liu, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311890 · Cited by 983
Self-citationCushman, W. C., Ford, C. E., Cutler, J. A., Margolis, K. L., Davis, B. R., Grimm, R. H., Black, H. R., Hamilton, B. P., Holland, J., Nwachuku, C., et al. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.02045.x · Cited by 979
Yusuf, S., Islam, S., Chow, C. K., Rangarajan, S., Dagenais, G., Diaz, R., Gupta, R., Kelishadi, R., Iqbal, R., Avezum, A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61215-4 · Cited by 964
Self-citationOlsen, M. H., Angell, S. Y., Asma, S., Boutouyrie, P., Burger, D., Chirinos, J. A., Damasceno, A., Delles, C., Gimenez-Roqueplo, A.-P., Hering, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31134-5 · Cited by 939
Self-citation
Cited by
Zhou, B., Carrillo-Larco, R. M., Danaei, G., Riley, L. M., Paciorek, C. J., Stevens, G. A., Gregg, E. W., Bennett, J. E., Solomon, B., Singleton, R. K., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01330-1 · Cited by 3,902
Self-citationGlobal Vascular Guidelines on the management of chronic limb-threatening ischemia.
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.02.016 · Cited by 2,015
Zhou, B., Perel, P., Mensah, G. A., & Ezzati, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00559-8 · Cited by 1,521
Global vascular guidelines on the management of chronic limb-threatening ischemia
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.05.006 · Cited by 1,582
Stark, B. A., DeCleene, N. K., Desai, E. C., Hsu, J. M., Johnson, C. O., Lara-Castor, L., LeGrand, K. E., A, P. B., Aalipour, M. A., Aalruz, H., et al. (2025) · JACC · doi:10.1016/j.jacc.2025.08.015 · Cited by 672
Metadata
- Authors
- Attaei, M. W., Khatib, R., McKee, M., Lear, S., Dagenais, G., Igumbor, E. U., AlHabib, K. F., Kaur, M., Kruger, L., Teo, K., Lanas, F., Yusoff, K., Oguz, A., Gupta, R., Yusufali, A. M., Bahonar, A., Kutty, R., Rosengren, A., Mohan, V., Avezum, A., Yusuf, R., Szuba, A., Rangarajan, S., Chow, C., Yusuf, S., Yusuf, S., Rangarajan, S., Teo, K. K., Chow, C. K., O'Donnell, M., Mente, A., Leong, D., Smyth, A., Joseph, P., Islam, S., Zhang, M., Hu, W., Ramasundarahettige, C., Wong, G., Dayal, L., Casanova, A., Dehghan, M., Lewis, G., Aliberti, A., Reyes, A., Zaki, A., Lewis, B., Zhang, B., Agapay, D., Hari, D., Milazzo, E., Ramezani, E., Hussain, F., Shifaly, F., Kay, I., Rimac, J., Swallow, J., Heldman, L., Mushtaha, M., Mushtaha, M., Trottier, M., Aoucheva, N., Kandy, N., Mackie, P., Solano, R., Chin, S., Ramacham, S., Shahrook, S., Trottier, S., Tongana, T., ElSheikh, W., Lindeman, J., McQueen, M., Hall, K., Keys, J., Wang, X., Keneth, J., Devanath, A., Diaz, R., Orlandini, A., Linetsky, B., Toscanelli, S., Casaccia, G., Maini Cuneo, J., Rahman, O., Yusuf, R., Azad, A., Rabbani, K., Cherry, H., Mannan, A., Hassan, I., Talukdar, A., Tooheen, R., Khan, M., Sintaha, M., Choudhury, T., Haque, R., Parvin, S., Avezum, A., Oliveira, G., Marcilio, C., Mattos, A., Teo, K., Yusuf, S., Dejesus, J., Agapay, D., Tongana, T., Solano, R., Kay, I., Trottier, S., Rimac, J., Elsheikh, W., Heldman, L., Ramezani, E., Dagenais, G., Poirier, P., Turbide, G., Auger, D., De Bluts, A. L., Proulx, M., Cayer, M., Bonneville, N., Lear, S., Gasevic, D., Corber, E., de Jong, V, Vukmirovich, I., Wielgosz, A., Fodor, G., Pipe, A., Shane, A., Lanas, F., Seron, P., Martinez, S., Valdebenito, A., Oliveros, M., Wei, L., Lisheng, L., Chunming, C., Xingyu, W., Wenhua, Z., Hongye, Z., JiaXuan, Bo, H., Yi, S., Jian, B., Xiuwen, Z., Xiaohong, C., Tao, C., Hui, C., Xiaohong, C., Qing, D., Xiaoru, C., Qing, D., Xinye, H., Bo, H., JiaXuan, Jian, L., Juan, L., Xu, L., Bing, R., Yi, S., Wei, W., Yang, W., Jun, Y., Yi, Z., Hongye, Z., Xiuwen, Z., Manlu, Z., Fanghong, L., Jianfang, W., Yindong, L., Yan, H., Liangqing, Z., Baoxia, G., Xiaoyang, L., Shiying, Z., BianRongwen, TianXiuzhen, Dong, L., Di, C., Jianguo, W., Yize, X., Tianlu, L., Peng, Z., Changlin, D., Ning, L., Xiaolan, M., Yuqing, Y., Rensheng, L., Minfan, F., Jing, H., Yu, L., Xiaojie, X., Qiang, Z., Lopez-Jaramillo, P., Lopez, P. C., Garcia, R., Jurado, L., Gómez-Arbeláez, D., Arguello, J., Dueñas, R., Silva, S., Pradilla, L., Ramirez, F., Molina, D., Cure-Cure, C., Perez, M., Hernandez, E., Arcos, E., Fernandez, S., Narvaez, C., Paez, J., Sotomayor, A., Garcia, H., Sanchez, G., David, T., Rico, A., Mony, P., Vaz, M., Bharathi, A. V., Swaminathan, S., Shankar, K., Kurpad, A., Jayachitra, K., Kumar, N., Hospital, H., Mohan, V, Deepa, M., Parthiban, K., Anitha, M., Hemavathy, S., Rahulashankiruthiyayan, T., Anitha, D., Sridevi, K., Gupta, R., Panwar, R., Mohan, I., Rastogi, P., Rastogi, S., Bhargava, R., Kumar, R., Thakur, J. S., Patro, B., Lakshmi, P., Mahajan, R., Chaudary, P., Kutty, V. R., Vijayakumar, K., Ajayan, K., Rajasree, G., Renjini, A., Deepu, A., Sandhya, B., Asha, S., Soumya, H., Kelishadi, R., Bahonar, A., Mohammadifard, N., Heidari, H., Yusoff, K., Ismail, T., Ng, K., Devi, A., Nasir, N., Yasin, M., Miskan, M., Rahman, E., Arsad, M., Ariffin, F., Razak, S., Majid, F., Bakar, N., Yacob, M., Zainon, N., Salleh, R., Ramli, M., Halim, N., Norlizan, Sr., Ghazali, N., Arshad, M., Razali, R., Ali, S., Othman, H., Hafar, C., Pit, A., Danuri, N., Basir, F., Zahari, S., Abdullah, H., Arippin, M., Zakaria, N., Noorhassim, I., Hasni, M., Azmi, M., Zaleha, M., Hazdi, K., Rizam, A., Sazman, W., Azman, A., Khatib, R., Khammash, U., Khatib, A., Giacaman, R., Iqbal, R., Afridi, A., Khawaja, R., Raza, A., Kazmi, K., Dans, A., Co, H., Sanchez, J., Pudol, L., Zamora-Pudol, C., Palileo-Villanueva, L., Aquino, M., Abaquin, C., Pudol, S., Cabral, M., Zatonski, W., Szuba, A., Zatonska, K., Ilow#, R., Ferus, M., Regulska-Ilow, B., Różańska, D., Wolyniec, M., AlHabib, K., Hersi, A., Kashour, T., Alfaleh, H., Alshamiri, M., Altaradi, H., Alnobani, O., Bafart, A., Alkamel, N., Ali, M., Abdulrahman, M., Nouri, R., Kruger, A., Voster, H. H., Schutte, A. E., Wentzel-Viljoen, E., Eloff, F., de Ridder, H., Moss, H., Potgieter, J., Roux, A., Watson, M., de Wet, G., Olckers, A., Jerling, J., Pieters, M., Hoekstra, T., Puoane, T., Igumbor, E., Tsolekile, L., Sanders, D., Naidoo, P., Steyn, N., Peer, N., Mayosi, B., Rayner, B., Lambert, V, Levitt, N., Kolbe-Alexander, T., Ntyintyane, L., Hughes, G., Swart, R., Fourie, J., Muzigaba, M., Xapa, S., Gobile, N., Ndayi, K., Jwili, B., Ndibaza, K., Egbujie, B., Rosengren, A., Boström, K. B., Lindblad, U., Langkilde, P., Gustavsson, A., Andreasson, M., Snällman, M., Wirdemann, L., Pettersson, K., Moberg, E., Yeates, K., Sleeth, J., Kilonzo, K., Oguz, A., Akalin, A., Calik, K., Imeryuz, N., Temizhan, A., Alphan, E., Gunes, E., Sur, H., Karsidag, K., Gulec, S., Altuntas, Y., Yusufali, A., Almahmeed, W., Swidan, H., Darwish, E., Hashemi, A., Al-Khaja, N., Muscat-Baron, J., Ahmed, S., Mamdouh, T., Darwish, W., Abdelmotagali, M., Awed, S. O., Movahedi, G., Hussain, F., Shaibani, H. A., Gharabou, R., Youssef, D., Nawati, A., Salah, Z. A., Abdalla, R., Shuwaihi, S. A., Omairi, M. A., Cadigal, O., Alejandrino, R. S., Chifamba, J., Gwaunza, L., Terera, G., Mahachi, C., Murambiwa, P., Machiweni, T., & Mapanga, R.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- Post Graduate Institute of Medical Education and Research (IN)
- Dubai Health Authority (AE)
- Health Action by People (IN)
- Population Health Research Institute (CA)
- The University of Sydney (AU)
- Wroclaw Medical University (PL)
- University of Gothenburg (SE)
- Loyola University Medical Center (US)
- Isfahan University of Medical Sciences (IR)
- North-West University (ZA)
- Madras Diabetes Research Foundation (IN)
- UCSI University (MY)
- Simon Fraser University (CA)
- King Saud University (SA)
- University of the Western Cape (ZA)
- Istanbul Medeniyet University (TR)
- Corresponding author
- O'Donnell, M
- Zhang, M
- Dayal, L
- Dehghan, M
- Shifaly, F
- Trottier, M
- McQueen, M
- Sintaha, M
- Cayer, M
- Oliveros, M
- Wei, Li
- Ning, Li
- Ramirez, F
- Perez, M
- Vaz, M
- Parthiban, K
- Hemavathy, S
- Rahman, EA
- Razak, SA
- Majid, FA
- Zainon, N
- Othman, HR
- Zahari, SNA
- Arippin, MA
- Zamora-Pudol, C
- Alshamiri, M
- Altaradi, HB
- Abdulrahman, M
- Nouri, R
- Moss, H
- Potgieter, J
- Hoekstra, T
- Sanders, D
- Hughes, G
- Xapa, S
- Snällman, M
- Wirdemann, L
- Pettersson, K
- Karsidag, K
- Darwish, EA
- Shaibani, H Al
- Terera, G
- ORCID
- McKee, Martin
- Kaur, Manmeet
- Yusufali, Afzalhussein M
- O'Donnell, M
- Mente, A
- Leong, D
- Smyth, A
- Joseph, P
- Islam, S
- Hu, W
- Ramasundarahettige, C
- Wong, G
- Casanova, A
- Dehghan, M
- Reyes, A
- Zaki, A
- Lewis, B
- Trottier, M
- Devanath, A
- Rahman, O
- Mannan, A
- Sintaha, M
- Choudhury, T
- Dejesus, J
- Poirier, P
- Cayer, M
- Wielgosz, A
- Pipe, A
- Martinez, S
- Oliveros, M
- Garcia, R
- Gómez-Arbeláez, D
- Mony, P
- Vaz, M
- Swaminathan, S
- Kumar, N
- Deepa, M
- Mohan, I
- Kumar, R
- Thakur, J S
- Patro, B
- Lakshmi, PVM
- Kutty, V Raman
- Vijayakumar, K
- Kelishadi, R
- Mohammadifard, N
- Heidari, H
- Miskan, M
- Ariffin, F
- Zainon, N
- Salleh, R
- Ali, S
- Azman, A
- Khammash, U
- Giacaman, R
- Kazmi, K
- Różańska, D
- Hersi, A
- Kashour, T
- Alfaleh, H
- Alshamiri, M
- Ali, M
- Abdulrahman, M
- Nouri, R
- Kruger, A
- Schutte, A E
- Watson, M
- Olckers, A
- Pieters, M
- Hoekstra, T
- Puoane, T
- Tsolekile, L
- Sanders, D
- Peer, N
- Mayosi, B
- Rayner, B
- Levitt, N
- Kolbe-Alexander, T
- Swart, R
- Fourie, J
- Muzigaba, M
- Egbujie, B
- Boström, K Bengtsson
- Yeates, K
- Sleeth, J
- Kilonzo, K
- Akalin, AAK
- Temizhan, A
- Sur, H
- Almahmeed, W
- Chifamba, J
- Gwaunza, L
- Mahachi, C
- Venue
- The Lancet Public Health
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 2
- Issue
- 9
- Pages
- e411-e419
- ISSN
- 2468-2667 (ISSN-L)
- OpenAlex
- W2751849735
- Cited by
- 209
- References
- 37
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 27 · 2023: 21 · 2022: 23 · 2021: 29 · 2020: 34 · 2019: 17 · 2018: 17 · 2017: 1
- FWCI
- 14.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The Lancet Public Health (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Boloka Institutional Repository (North-west University) (submittedVersion)
- Funders
- AstraZeneca Canada
- Boehringer Ingelheim
- Indian Council of Medical Research
- AFA Försäkring
- Ministerstwo Nauki i Szkolnictwa Wyższego (290/W-PURE/2008/0)
- Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010)
- Deanship of Scientific Research, King Saud University (RG -1436-013)
- South Africa Netherlands research Programme on Alternatives in Development
- Svenska Forskningsrådet Formas
- Universiti Teknologi MARA
- North-West University
- Ministry of Higher Education, Malaysia (600-RMI/LRGS/5/3 [2/2011)
- Philippine Council for Health Research and Development
- Heart and Stroke Foundation of Canada
- Servier
- International Development Research Centre
- United Arab Emirates University
- Canadian Institutes of Health Research
- GlaxoSmithKline
- Forskningsrådet för Arbetsliv och Socialvetenskap
- Universidad de La Frontera
- Vetenskapsrådet
- Public Health Agency of Canada
- Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences
- Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Systems and Reforms
- Keywords
- hypertension, drug affordability, blood pressure control, combination therapy, generic drugs, economic development, PURE study, India, low-income countries, middle-income countries, high-income countries, cardiovascular risk factors, access to medicines
- MeSH terms
- Aged, Antihypertensive Agents, Developing Countries, Female, Humans, Hypertension, Income, Male, Middle Aged, Treatment Outcome, Developed Countries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. https://app.cochat.ai/papers/10.1016/s2468-2667(17)30141-x
- The paper
- Attaei, M. W., Khatib, R., McKee, M., Lear, S., Dagenais, G., Igumbor, E. U., AlHabib, K. F., Kaur, M., Kruger, L., Teo, K., Lanas, F., Yusoff, K., Oguz, A., Gupta, R., Yusufali, A. M., Bahonar, A., Kutty, R., Rosengren, A., Mohan, V., . . . Mapanga, R. (2017). Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. The Lancet Public Health. https://doi.org/10.1016/s2468-2667(17)30141-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.